Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing-Reference-Cited by-同舟云学术

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

Published:2021-02-22 Issue:3 Volume:27 Page:491-503
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Cohen Yael C.^ORCID,Zada Mor,Wang Shuang-Yin^ORCID,Bornstein Chamutal,David Eyal,Moshe Adi,Li Baoguo,Shlomi-Loubaton Shir,Gatt Moshe E.,Gur Chamutal,Lavi Noa,Ganzel Chezi^ORCID,Luttwak Efrat^ORCID,Chubar Evgeni,Rouvio Ory,Vaxman Iuliana^ORCID,Pasvolsky Oren,Ballan Mouna,Tadmor Tamar,Nemets Anatoly,Jarchowcky-Dolberg Osnat,Shvetz Olga,Laiba Meirav,Shpilberg Ofer,Dally Najib,Avivi Irit,Weiner Assaf,Amit Ido^ORCID

Funder

Amgen

European Molecular Biology Organization

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-021-01232-w.pdf

Reference52 articles.

1. Kyle, R. A. & Rajkumar, S. V. Treatment of multiple myeloma: a comprehensive review. Clin. Lymphoma Myeloma 9, 278–288 (2009).

2. Palumbo, A. & Anderson, K. Multiple myeloma. N. Engl. J. Med. 364, 1046–1060 (2011).